Drug Profile
CTCE 0324
Alternative Names: CTCE-0324Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Chemokine Therapeutics
- Class Chemokines; Vascular disorder therapies
- Mechanism of Action Angiogenesis inducing agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Peripheral vascular disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Peripheral-vascular-disorders in Canada (Parenteral, Injection)
- 25 Jul 2006 Preclinical data from a media release have been added to the Vascular disorders pharmacodynamics section
- 07 Mar 2006 Preclinical trials in Peripheral vascular disorders in Canada (Parenteral)